|
|
Is Marijuana Beneficial for Prevention and Treatment of Diabetes? |
Rui Cao1,2*, Jun Wang1*#, Wei Zhang1, Huang Huang1, Yu Qiao3, Yufan Dai4, |
Miaozi Gong5, Hong C. Lai6 |
1Department of Pharmacology, Bioengineering
and Food College, Hubei University of Technology, Wuhan, Hubei 430068, China |
2Department of Chemistry,
Johns Hopkins University, Baltimore, MD 21218, USA |
3Research Institute of
Agricultural Products Processing and Nuclear-Agricultural Technology, Hubei
Academy of Agricultural Sciences, Wuhan 430064, China |
4School of Physics and
Technology, Wuhan University, Wuhan 430072, China |
5Department of Pathology,
Peking University Shougang Hospital, Beijing 100144,
China |
*These
two authors contribute equally to this paper. |
#Corresponding
Author |
Jun
Wang |
Department of Pharmacology |
Bioengineering and Food
College |
Hubei University of
Technology |
Wuhan, Hubei 430068 |
China |
Email: 2491549178@qq.com |
Abstract Marijuana is classified as Cannabis saiva L, one type of hemp. Traditionally, Marijuana is considered as Schedule I drug due to its acute bad effects on human health. However, its medical use has been widely recognized today. Delta-9-tetrahydrocannabinol (D9-THC) is a compound extracted from Marijuana, which has been used in several drugs approved by United States Food and Drug Administration (FDA). D9-THC functions through cannabinoid receptor in neural system or peripheral tissues. For diabetes patients, D9-THC has been reported to have preventative or treatment effects. In this paper, we will review recent research progress in association between cannabis use and diabetes, as well as known mechanism of how D9-THC functions in human from the perspective of free radicals. Keywords: cannabis, diabetes, Delta-9-tetrahydrocannabinol, free radicals Download the full article (PDF)
|
Publisher | Missions and Scope | Editorial Board | Instructions for Authors |
© American Journal of Biomedical Sciences 2007-2021. All Rights Reserved. |